BioSpace News Archive

Latest data on lecanemab to be presented at Alzheimer’s Association International Conference (AAIC) 2023

BioArctic AB’s partner Eisai will present the latest findings on lecanemab, an anti-amyloid beta protofibril antibody for the treatment of Alzheimer’s disease, at the Alzheimer’s Association International Conference.

July 11, 2023
·
6 min read
Pharm Country

The Leukemia & Lymphoma Society Makes Fast Company’s Fifth Annual List of the Best Workplaces for Innovators in Nonprofit Category

Fast Company announced its fifth annual Best Workplaces for Innovators list, honoring organizations and businesses that demonstrate an inspiring commitment to encourage and develop innovation at all levels.

July 11, 2023
·
5 min read
Biotech Beach

CHA Hollywood Presbyterian to Participate in $40 Million Study of Alzheimer’s Disease in Persons of Korean, Vietnamese, and Chinese Ancestry

CHA Hollywood Presbyterian Medical Center is proud to announce its participation in a prestigious $40.5 million, multisite study funded by a grant from the National Institute on Aging, part of the National Institutes of Health, for the development of the Asian Cohort for Alzheimer’s Disease.

July 11, 2023
·
5 min read
Business

Glauconix is Now Humonix

What began as a specialization in glaucoma therapeutics has become a launchpad for developing new fibrotic and vascular 3D human tissue models.

July 11, 2023
·
1 min read
Pharm Country

ZEISS Microscopy Showcases New Product Launch and New Researchers in Interactive Display Features at Microscopy and Microanalysis (M&M) 2023 Conference

ZEISS is unveiling two highlights at M&M 2023, in Minneapolis, MN, from July 23 to July 27, 2023.

July 11, 2023
·
4 min read
BioMidwest

LARGEST STUDY ON RACIAL DIFFERENCES IN MEN WITH MELANOMA SHOWS MEN WITH SKIN OF COLOR HAVE LOWEST SURVIVAL RATES

Melanoma, the most serious form of skin cancer, is highly treatable when detected early, but when the disease advances, it can lead to death.

July 11, 2023
·
4 min read
Business

Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2023 Financial Results

Neurocrine Biosciences, Inc. announced that it has scheduled its second quarter 2023 financial results conference call and webcast for 5:00 a.m. Pacific Time on August 1, 2023.

July 11, 2023
·
1 min read
Pharm Country

PTC Therapeutics Announces Virtual Presentation on Phenylketonuria (PKU) and Sepiapterin

PTC Therapeutics, Inc., announced that the company will provide a virtual presentation on PKU including discussion of the current therapeutic and commercial landscape with an expert key opinion leader.

July 11, 2023
·
2 min read
Business

CytoDyn Announces Company Updates and Investment Community Update Webcast

CytoDyn Inc. announced that it has filed a supplemental Statement of Claim and formally requested a hearing date in its litigation proceeding against Amarex Clinical Research LLC, the Company’s former Contract Research Organization.

July 11, 2023
·
7 min read
Business

Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer

Azitra, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, announced the appointment of Travis Whitfill as Chief Operating Officer.

July 11, 2023
·
3 min read